Cara Therapeutics | CARA - Trade Creditors

Stock Price
3.17
Daily Change
-0.16 -4.80%
Monthly
-19.95%
Yearly
-79.48%
Q1 Forecast
3.19

Cara Therapeutics reported $2.42M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Assertio Holdings USD 14.66M 3.81M Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Chugai Pharma JPY 127.25B 48.35B Dec/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
RedHill Biopharma USD 835K 7.03M Jun/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024